Vaccinex’s lead asset is being evaluated in neurodegenerative and oncological indications. Image credit: Shutterstock/interstid. Despite reporting positive Phase II results for its lead candidate last
Credit: Lightspring/Shutterstock.com A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into
Novo is launching a direct-to-patient option for Wegovy to cut out ‘middle-men’. Image credit: Shutterstock/ KK Stock. Novo Nordisk is introducing a direct-to-patient delivery option
Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies in 2025. Image credit: Shutterstock/ T. Schneider. Sandoz reported
Genentech’s TNKase was originally approved for heart attacks and acute myocardial infarctions in 2000. Image credit: Shutterstock / Sundry Photography. Genentech has secured a second
Around 3.5 million people in the UK live with a rare disease, according to government data. Image credit: Shutterstock / H_Ko. UK patients living with
Current paediatric standard-of-care for galactosemia is a lactose-free diet. Image credit: Shutterstock / Photoongraphy. Nearly three months after an experimental treatment for classic galactosemia was
GSK was one of the UK pharma companies that invested in an US acquisition in January. Image credit: Shutterstock/ lunopark. The number of deals in
Idorsia has executed cost saving programmes and restructuring paths amid struggling financials. Image credit: Shutterstock/ Taljat David. A deal that would have seen Idorsia sell
J&J has reached several deals with pharma companies permitting biosimilar commercialisation after Stelara’s patent expired in July 2024. Image credit: Shutterstock/ Michael Vi. Johnson &